You are here

How Singapore can lead biopharma innovation

The Republic needs to align its patent term extension regime with international standards, and so start attracting more clinical trials.

BT_20200304_AJPHARM_4050758.jpg
For pharmaceutical companies, patents are the primary way to offset the high R&D costs that can stretch over decades, and ensure sustainable investment into the medicines of tomorrow.

SINGAPORE is known by the global innovation and intellectual property (IP) expert community as a leader in the protection of IP rights. The latest International Property Rights Index for 2019 again listed Singapore as having Asia's strongest protection of intellectual property (IP) rights;...